AI Article Synopsis
- * One patient showed severe hypoxaemia and dyspnoea, with a worsened status classified as IPOS 3.
- * Along with standard treatments like remdesivir and dexamethasone, morphine was given and resulted in unexpected improvement in both hypoxaemia and dyspnoea.
Article Abstract
At present, the world is undergoing successive waves of the COVID-19 pandemic. When COVID-19 becomes severe, it causes respiratory failure and symptoms of dyspnoea. The patient's dyspnoea worsens to the IPOS of 3. One COVID-19 patient admitted to our medical institution developed severe illness characterised by hypoxaemia and dyspnoea. In addition to disease-modifying treatments such as remdesivir and dexamethasone, we administered morphine to relieve his dyspnoea. Surprisingly, we observed an improvement in both hypoxaemia and dyspnoea.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168286 | PMC |
| http://dx.doi.org/10.25259/IJPC_132_2021 | DOI Listing |
Publication Analysis
Top Keywords
respiratory failure
8
hypoxaemia dyspnoea
8
dyspnoea
5
morphine contribute
4
contribute improving
4
improving respiratory
4
failure severe
4
covid-19
4
severe covid-19
4
covid-19 case
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!